drugset / Trial / NCT01361555
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study it to evaluate the long-term safety and tolerability of BMS-820836 in patients with depression.
Timeline
- Start
- 2011-08
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liafensine | Small molecule | 0.5 mg | Oral |
| Subject | Liafensine | Small molecule | 1 mg | Oral |
| Subject | Liafensine | Small molecule | 2 mg | Oral |